Stock Market Today: S&P 500, Dow Futures Down Ahead Of ''Triple Witching'' As Iran Warns Of ''Zero Restraint''—FedEx, Super Micro Computer In Focus (news.google.com)
Lilly''s triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes (news.google.com)